A picture may be worth a thousand words, but when it comes to disease discovery, Bay Area VC firm Third Rock Ventures is betting its money on moving pictures. But instead of Hollywood blockbusters, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the formation of Relay Therapeutics with $57 million in Series A financing, including participation from an affiliate of D.

A discovery-stage biopharma startup focused on protein motion in drug discovery has raised a round of financing more than six times as big as the last one. Relay Therapeutics, based in Cambridge, ...

Relay Therapeutics, which aims to take down difficult cancer drug targets by combining powerful computational methods with emerging lab tools, has raised a whopping $400 million in its third formal ...